Accelerated α-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells

被引:68
作者
Hasegawa, T
Matsuzaki, M
Takeda, A
Kikuchi, A
Akita, H
Perry, G
Smith, MA
Itoyama, Y
机构
[1] Tohoku Univ, Sch Med, Dept Neurol, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Grad Sch Dent, Div Oral Mol Biol, Sendai, Miyagi 9808575, Japan
[3] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
关键词
alpha-synuclein; lexvy body; Parkinson's disease; neuroblastoma; iron; aggregation;
D O I
10.1016/j.brainres.2004.04.018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
alpha-Synticlein (alpha-syn) is a major component of inclusion bodies in Parkinson's disease (PD) and other synucleinopathies. To clarify the possible roles of a-syn in the molecular pathogenesis of neurodegenerative diseases, we have established a novel cellular model based on the differentiation of SH-SY5Y cells that overexpress alpha-syn. In the presence of ferrous iron, differentiation of the cells led to the formation of large perinuclear inclusion bodies, which developed from scattered small aggregates seen in undifferentiated cells. The iron-induced alpha-synpositive inclusions co-localized largely with ubiquitin, and some of them were positive for nitrotyrosine, lipid, gamma-tubulin and dynein. Notably, treatment with nocodazole, a microtubule depolymerizing agent, interrupted the aggregate formation but led to a concomitant increase of apoptotic cells. Therefore, it appears that an intracellular retrograde transport system via inicrotubules plays a crucial role in the aggregate formation and also that the aggregates may represent a cytoprotective response against noxious stimuli. This cellular model will enable better understanding of the molecular pathomechanisms of synucleinopathy. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 55 条
[1]   Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease [J].
Auluck, PK ;
Chan, HYE ;
Trojanowski, JQ ;
Lee, VMY ;
Bonini, NM .
SCIENCE, 2002, 295 (5556) :865-868
[2]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[3]   Degradation of α-synuclein by proteasome [J].
Bennett, MC ;
Bishop, JF ;
Leng, Y ;
Chock, PB ;
Chase, TN ;
Mouradian, MM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) :33855-33858
[4]   Centrosome composition and microtubule anchoring mechanisms [J].
Bornens, M .
CURRENT OPINION IN CELL BIOLOGY, 2002, 14 (01) :25-34
[5]  
Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.0.CO
[6]  
2-E
[7]   Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
NATURE MEDICINE, 1998, 4 (11) :1318-1320
[8]   Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies [J].
Duda, JE ;
Giasson, BI ;
Chen, QP ;
Gur, TL ;
Hurtig, HI ;
Stern, MB ;
Gollomp, SM ;
Ischiropoulos, H ;
Lee, VMY ;
Trojanowski, JQ .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (05) :1439-1445
[9]   Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells [J].
Encinas, M ;
Iglesias, M ;
Liu, YH ;
Wang, HY ;
Muhaisen, A ;
Ceña, V ;
Gallego, C ;
Comella, JX .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (03) :991-1003
[10]   In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin, and lipids in Lewy bodies [J].
Gai, WP ;
Yuan, HX ;
Li, XQ ;
Power, JTH ;
Blumbergs, PC ;
Jensen, PH .
EXPERIMENTAL NEUROLOGY, 2000, 166 (02) :324-333